(Q37202179)

18 August 2017

Aspirin use is associated with an improved long-term survival in an unselected population presenting with unstable angina (English)

1 reference

18 August 2017

1 reference

7

Paul Muntner

1 reference

18 August 2017

6

Heather J Wiste

1 reference

18 August 2017

Louai Razzouk

1

1 reference

18 August 2017

Verghese Mathew

2

1 reference

18 August 2017

Ryan J Lennon

3

1 reference

18 August 2017

Ashish Aneja

4

1 reference

18 August 2017

Joshua I Mozes

5

1 reference

18 August 2017

James H Chesebro

8

1 reference

18 August 2017

Michael E Farkouh

9

1 reference

18 August 2017

1 September 2010

1 reference

18 August 2017

1 reference

18 August 2017

33

1 reference

18 August 2017

9

1 reference

18 August 2017

553-558

1 reference

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Short-term and long-term outcomes in 133,429 emergency patients admitted with angina or myocardial infarction in Scotland, 1990-2000: population-based cohort study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

The mechanism of action of aspirin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Statistical significance versus clinical relevance in cardiovascular medicine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Inhibition of platelet prostaglandin synthetase by oral aspirin

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

A case-control study of regular aspirin use and coronary deaths

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3785089

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

26 June 2018

1 reference

12 December 2020

The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group

1 reference

12 December 2020

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group

1 reference

12 December 2020

Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes

1 reference

12 December 2020

Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia

1 reference

12 December 2020

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

1 reference

12 December 2020

Randomized controlled trials do not reflect reality: real-world analyses are critical for treatment guidelines!

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.20769

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

20842739

1 reference